Impact of age on cardiovascular drug use in patients with chronic kidney disease.

Journal: Clinical kidney journal
Published Date: Jun 10, 2019

Abstract

BACKGROUND: Elderly patients with chronic kidney disease (CKD) are often excluded from clinical trials; this may affect their use of essential drugs for cardiovascular complications. We sought to assess the impact of age on cardiovascular drug use in elderly patients with CKD.

Authors

  • Cédric Villain
    Service de Néphrologie-Dialyse, CHU Ambroise Paré, APHP, Boulogne-Billancourt, France.
  • Sophie Liabeuf
    CESP, INSERM Unité 1018, Equipe 5 EpRec, Université Paris-Sud, UVSQ, Université Paris-Saclay, Villejuif, France.
  • Marie Metzger
    French Institute of Health and Medical Research (INSERM), Villejuif, France.
  • Christian Combe
    Service de Néphrologie Transplantation Dialyse Aphérèses, CHU de Bordeaux, Bordeaux, France.
  • Denis Fouque
    Department of Nephrology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.
  • Luc Frimat
    CHRU Nancy-Brabois, Vandœuvre-lès-Nancy, France.
  • Christian Jacquelinet
    CESP, INSERM Unité 1018, Equipe 5 EpRec, Université Paris-Sud, UVSQ, Université Paris-Saclay, Villejuif, France.
  • Maurice Laville
    Université de Lyon, Service de Néphrologie, CarMeN INSERM 1060, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.
  • Serge Briançon
    INSERM CIC-EC CIE6 - EA 4360 Apemac, Nancy Université, Vandœuvre-lès-Nancy, France.
  • Ronald L Pisoni
    Arbor Research Collaborative for Health, Ann Arbor, Michigan.
  • Nicolas Mansencal
    CESP, INSERM Unité 1018, Equipe 5 EpRec, Université Paris-Sud, UVSQ, Université Paris-Saclay, Villejuif, France.
  • Bénédicte Stengel
    French Institute of Health and Medical Research (INSERM), Villejuif, France.
  • Ziad A Massy
    Division of Nephrology, Ambroise Paré University Medical Center, APHP, Boulogne Billancourt, Paris, France.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals